Sarah Khalifa, a prominent Egyptian television host, was sentenced to death by hanging on Saturday in connection with a sophisticated drug trafficking operation that authorities say distributed over 750 kilograms of synthetic narcotics through Cairo.
Khalifa, who hosted the Egyptian crime drama "Mission Impossible" and has over 2.5 million Instagram followers, was convicted alongside 11 other defendants. Nine additional defendants received life sentences, while seven were acquitted. The court's decision concludes a months-long investigation that began with Khalifa's arrest in Cairo in April.
Prosecutors described the operation as a meticulously organized criminal enterprise with a vertically integrated structure. Different defendants allegedly occupied distinct roles: some handled importation of precursor chemicals, others managed production in a residential property, and still others ran distribution networks.
The case relied on testimony from 20 witnesses and what prosecutors characterized as technical and digital evidence, including communications, photographs and video documentation. Authorities also seized unlicensed firearms and ammunition, suggesting the organization took security seriously.
Khalifa's dual identity as a public figure and alleged trafficker raised questions about how someone so visible could operate in a criminal network. According to the investigation, she was a documented member of the organized group and not hiding her involvement.
Authorities froze defendants' assets and bank accounts as precautionary measures, though the prosecution has not disclosed specifics about the scale or destination of financial flows.
Egypt maintains a hardline stance on drug trafficking, and capital punishment for narcotics offenses is swift by global standards. The 12 death sentences represent the judicial system's maximum response to the alleged crime.
The case exemplifies a pattern emerging across the Middle East and North Africa: the rise of sophisticated domestic drug production and trafficking operations. Rather than simply importing finished products, these networks manufacture synthetics domestically, reducing supply chain vulnerability and increasing profit margins.
Details about the supply chain's origin, the specific synthetic drugs produced, and the extent of the distribution network remain unclear from available reports. Similarly, the reasons for the acquittal of seven defendants have not been disclosed.